http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102558312-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d94573ab2c57e8b193f3a22accddf9fe |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a282e1d92096d331575d9d5be2db812e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dccb50e993bfa7589a62a3db19fcd10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaccafd42a931433c38979218511ade1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a12b5f762388433f7e5e9100c51e7390 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c8bece091d32968b0608cb79efe11a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_672b002764077f11051a1921e769a052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae54a0a2d5c45ac1baa988fffef5fe86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_364170efe6f167a36d785fbdf26207ed |
| publicationDate | 2014-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102558312-B |
| titleOfInvention | New mutant protein of chronic viral hepatitis B related gene NLRX1, coding gene and application of coding gene |
| abstract | The invention discloses a new mutant protein of a chronic viral hepatitis B related gene NLRX1, a coding gene and application of the coding gene. According to the new mutant protein of the chronic viral hepatitis B related gene NLRX1, the 707th arginine of an amino acid sequence of chronic viral hepatitis B related gene NLRX1 protein is mutated into cysteine, meanwhile, the coding gene of the mutant protein is obtained, a diagnostic kit based on the gene NLRX1 and the mutant thereof is established, and the kit can be used for diagnosis of the gene level of a chronic hepatitis B patient in clinic and guidance and individual treatment of the clinical medication condition. On a long view, the disease may be treated by a treatment method for correcting mutant genes or other methods aiming at the biological effect of the mutant in future by mutation detection of the gene NLRX1 of the chronic viral hepatitis B, so the new mutant protein has profound significance and application prospect in clinical treatment. |
| priorityDate | 2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 403.